Last updated on February 2018

Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events


Brief description of study

The protocol is a large registry to describe acute, sub-acute and extended duration of anticoagulation management, clinical and economic duration of anticoagulation management, clinical and economic outcomes in patients with treated acute VTE (DVT and PE) in the real-world setting.

Main objectives are to clarify the:

  • treatment related details for acute VTE (either conventional anticoagulation therapy, treatment with a direct oral anti-coagulant or other modalities of treatment)
  • Rate of early and late symptomatic VTE recurrence
  • Rate and nature of complications of VTE including post thrombotic syndrome and chronic thromboembolic pulmonary hypertension
  • Rate of bleeding complications
  • Rate of all-cause mortality at six months

Detailed Study Description

Other objectives are to clarify the additional outcomes of:

  • Stroke (Measured by number of incidences)
  • Transient Ischemic Attack (TIA) (Measured by number on incidences)
  • ST Elevated Myocardial Infarction (STEMI) (Measured by number of incidences)
  • Non-ST Elevated Myocardial Infraction (NSTEMI) (Measured by number of incidences)
  • Unstable Angina (Measured by number of incidences)
  • Quality of life and patient reported outcomes and costs associated with the management of VTE.

Clinical Study Identifier: NCT02155491

Contact Investigators or Research Sites near you

Start Over

Andrea Davis, RN

Dr Terence Hart
Muscle Shoals, AL United States
  Connect »